Martin Cranage

Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.

Martin Cranage, Tony Kouzarides, Alan T. Bankier et al. · The EMBO Journal · 1986 · 336 citations · Full text

Vaccination, Vaccine Development, Immunology +8

Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen

Tomáš Hanke, Rachel V. Samuel, Tom Blanchard et al. · Journal of Virology · 1999 · 306 citations · Full text

Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

Thomas Lehner, Yufei Wang, Martin Cranage et al. · Nature Medicine · 1996 · 294 citations · Full text

Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.

Leszek K. Borysiewicz, Julian Hickling, Shek Graham et al. · The Journal of Experimental Medicine · 1988 · 249 citations · Full text

Persistent Herpes-virus Infections, Ctl Response, Molecular Virology +15

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells

Neil Almond, Karen A. Kent, E. J. Stott et al. · The Lancet · 1995 · 220 citations

Vaccination, Virus-infected Cells, Viral Persistence +7